Why AgelessRx
When tirzepatide was on the FDA drug shortage list, Section 503A of the Federal Food, Drug, and Cosmetic Act allowed licensed compounding pharmacies to produce compounded versions
There are clinical trials evaluating if these GLP-1 and multi-agonists can address neurodegeneration, addiction, inflammation, and beyond
Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential
doi: 10.1007/s12325-013-0009-4 68 Roca-RodrguezMMMuros de FuentesMTPidrola-MarotoGQuesada-CharnecoMMaraver-SelfaSTinahonesFJet al
Vasconcelos SM, Goulart MO, Silva MA, Manfredini V, Benfato Mda S, Rabelo LA, et al